loadpatents
name:-0.018279075622559
name:-0.024884939193726
name:-0.0091190338134766
Okaniwa; Masanori Patent Filings

Okaniwa; Masanori

Patent Applications and Registrations

Patent applications and USPTO patent grants for Okaniwa; Masanori.The latest application filed is for "sting modulator compounds, and methods of making and using".

Company Profile
8.15.17
  • Okaniwa; Masanori - Kanagawa JP
  • OKANIWA; Masanori - Osaka JP
  • Okaniwa; Masanori - Fujisawa Kanagawa JP
  • Okaniwa; Masanori - Cambridge MA
  • Okaniwa; Masanori - Fujisawa JP
  • Okaniwa; Masanori - Tsukuba JP
  • Okaniwa; Masanori - Fujisawa-shi JP
  • Okaniwa; Masanori - Tsukuba-shi JP
  • Okaniwa; Masanori - Osaka-shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mtorc1 inhibitors
Grant 11,452,780 - Shokat , et al. September 27, 2
2022-09-27
Sting Modulator Compounds, And Methods Of Making And Using
App 20210171565 - VYSKOCIL; Stepan ;   et al.
2021-06-10
Antibody-drug Conjugates Comprising A Cyclic Dinucleotide
App 20210106607 - YOSHIKAWA; MASATO ;   et al.
2021-04-15
mTORC1 INHIBITORS
App 20210052735 - Shokat; Kevan ;   et al.
2021-02-25
Heterocyclic amide compound
Grant 10,800,754 - Hirayama , et al. October 13, 2
2020-10-13
Heterocyclic amide compound
Grant 10,774,083 - Hirayama , et al. Sept
2020-09-15
mTORC1 inhibitors
Grant 10,646,577 - Shokat , et al.
2020-05-12
Heterocyclic Amide Compound
App 20190359587 - HIRAYAMA; Takaharu ;   et al.
2019-11-28
Heterocyclic Amide Compound
App 20190241566 - HIRAYAMA; Takaharu ;   et al.
2019-08-08
Cyclic Dinucleotide
App 20190192549 - YOSHIKAWA; MASATO ;   et al.
2019-06-27
mTORC1 INHIBITORS
App 20190091340 - Shokat; Kevan ;   et al.
2019-03-28
mTORC1 inhibitors
Grant 10,117,945 - Shokat , et al. November 6, 2
2018-11-06
Heterocyclic compound
Grant 9,957,251 - Hirayama , et al. May 1, 2
2018-05-01
mTORC1 INHIBITORS
App 20170246305 - Shokat; Kevan ;   et al.
2017-08-31
Fused heterocyclic compound
Grant 9,745,325 - Okaniwa , et al. August 29, 2
2017-08-29
Heterocyclic Compound
App 20170044132 - HIRAYAMA; Takaharu ;   et al.
2017-02-16
Fused Heterocyclic Compound
App 20170037057 - Okaniwa; Masanori ;   et al.
2017-02-09
Heterocyclic compound and use thereof
Grant 8,697,874 - Okaniwa April 15, 2
2014-04-15
Heterocyclic compound and use thereof
Grant 8,497,274 - Okaniwa , et al. July 30, 2
2013-07-30
Heterocyclic compound and use thereof
Grant 8,344,135 - Hirose , et al. January 1, 2
2013-01-01
Heterocyclic compound and use thereof
Grant 8,324,395 - Hirose , et al. December 4, 2
2012-12-04
Heterocyclic Compound And Use Thereof
App 20120214855 - OKANIWA; Masanori ;   et al.
2012-08-23
Benzothiazole compounds useful for Raf inhibition
Grant 8,143,258 - Okaniwa , et al. March 27, 2
2012-03-27
Heterocyclic Compound And Use Thereof
App 20110237620 - Okaniwa; Masanori
2011-09-29
Heterocyclic Compound And Use Thereof
App 20110172245 - Hirose; Masaaki ;   et al.
2011-07-14
Pyrazoloquinolone derivative and use thereof
Grant 7,842,701 - Fukumoto , et al. November 30, 2
2010-11-30
Heterocyclic Compound And Use Thereof
App 20100249119 - Hirose; Masaaki ;   et al.
2010-09-30
Heterocyclic Compound And Use Thereof
App 20100216810 - OKANIWA; Masanori ;   et al.
2010-08-26
Fused Heterocycle Derivatives And Use Thereof
App 20090163488 - OGURO; Yuya ;   et al.
2009-06-25
Pyrazoloquinolone Derivative And Use Thereof
App 20070281963 - Fukumoto; Shojl ;   et al.
2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed